SmiLe Incubator

Call Knut is a developer of communication software focused on monitoring elderly individuals, particularly those with chronic diseases. The company offers an artificial intelligence-based eHealth care platform that facilitates phone calls and initiates automated conversations with elderly users. This technology allows caregivers to assess the recipient's voice and identify potential medical warning signals, promoting a more effective and less intrusive approach to elderly care. By leveraging advanced communication tools, Call Knut aims to enhance the well-being and safety of senior citizens.

TIGERQ is a sample-to-analysis gene editing solution that combines proprietary sequencing algorithms with cost-effective and rapid turnaround sample processing services. The company works with commercializing services related to the Nobel-prize awarded CRISPR-Cas9 method.

Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.

In2cure is a biotechnology company focused on developing peptide-based drugs aimed at preventing and treating inflammatory diseases and infections. The company leverages scientific discoveries related to natural host defenses to create novel therapies. In2cure specializes in peptides that possess anti-endotoxic properties, utilizing sequences that are identical to protein fragments naturally found in the human body. This approach allows for the production of anti-inflammatory drugs that are less toxic and more easily soluble, promoting the generation of healing peptides during instances of wounding and inflammation. Through its innovative research, In2cure strives to contribute to more effective and safer therapeutic options in the field of medicine.

Thyrolytics develops a first-of-its-kind diagnostic device for measuring serum levels of free T4 and T3.

Bionamic offers a data management platform designed to streamline the analysis of life science data, particularly in biopharma research and development. The platform acts as a centralized resource for antibody-related discovery and development data, allowing researchers to efficiently navigate and comprehend their data. By minimizing or eliminating manual processes between raw data and results, Bionamic enhances decision-making capabilities for researchers, ultimately contributing to advancements in the biopharmaceutical sector.

ReceptorPharma is a drug discovery company focused on developing innovative treatments for Alzheimer's disease and other debilitating conditions, including certain types of cancer. The company employs a novel mechanism of action that targets G-protein-coupled receptors to create therapies aimed at reversing disease progression. Specifically, ReceptorPharma concentrates on patients with early-stage Alzheimer's who retain their cognitive abilities, seeking to improve their quality of life through effective pharmaceutical interventions.

SAGA Diagnostics AB is a Swedish company specializing in molecular genetic testing and services aimed at healthcare and biopharmaceutical sectors, as well as academic institutions. Founded in 2016 and based in Lund, SAGA focuses on personalized cancer genomics and disease monitoring. The company provides cutting-edge services such as cancer medicine, gene mutation analysis, and both tissue and non-invasive liquid biopsies, including blood samples. SAGA's proprietary technology enables the ultrasensitive quantification of circulating tumor DNA, achieving a detection limit of 0.001%. This advanced capability allows for the accurate detection of actionable mutations, patient stratification, and monitoring of treatment responses, thereby enhancing the management of cancer therapies and providing patients with greater peace of mind.

Medotemic develops solutions for objective gait deviation analysis, e.g. resulting from injury or pain. Sensor data collected via the smartphone alone is analyzed via proprietary algorithms.

POOW Applications has developed The Food Hero app that helps children with different types of eating disorders.

Medow develops innovative health care products that bring efficiency, comfort and joy by using design and colour.

Truly Labs specializes in providing customized in vitro and in vivo services aimed at enhancing drug delivery and biomarker analysis. The company employs established kits to conduct comprehensive biomarker analysis, integrating these efforts into pharmacology programs. Their focus is on designing and executing tailored studies that supply essential information for preclinical development and clinical design. By serving large pharmaceutical and biotech companies, Truly Labs plays a crucial role in advancing the drug development process.

Gedea Biotech AB, founded in 2015 and based in Lund, Sweden, focuses on developing antibiotic-free treatments for vaginal fungal infections, a common issue affecting approximately 75% of women at some point in their lives. The company's primary product, GA101, is a natural substance that functions by lowering the pH in the vaginal environment, providing physical barrier protection, and inhibiting biofilm formation. This innovative approach aims to offer a safe and effective topical treatment for vaginal yeast infections, addressing a significant healthcare need without the use of antibiotics.

Cellevate AB is a biotech company based in Lund, Sweden, founded in 2014. It specializes in developing advanced 3D cell culture systems utilizing nanofiber scaffolds known as 3D NanoMatrix. These scaffolds facilitate the creation of realistic in-vitro models, which are essential for scientific research and development across various fields, including automotive, construction, defense, electronics, energy, environment, and healthcare. Cellevate's platform employs a patented manufacturing process to produce consistent and porous networks of nanofibers, enhancing the effectiveness of cell culture systems and supporting upstream bioprocessing efforts.

MedVasc is a company focused on developing innovative medical devices aimed at improving the treatment of varicose veins. It has created a patented device designed to enhance the anesthetic procedure, significantly reducing pain during treatment. By introducing advanced technology to the healthcare industry, MedVasc aims to improve patient comfort and outcomes in varicose vein treatments.

Speximo AB offers starch based technology to create surfactant-free Pickering type emulsions to be used in the manufacturing of skin lotions. The company was founded in 2012 and is based in Lund, Sweden. As of September 17, 2019, Speximo AB operates as a subsidiary of Lucas Meyer Cosmetics Canada, Inc.

SARomics Biostructures AB is a structural biology and structure-based drug discovery service provider based in Lund, Sweden. Founded in 2006, the company offers a comprehensive range of services to biotech and pharmaceutical companies, as well as non-profit institutions globally. These services include crystallography, NMR spectroscopy, and gene-to-structure capabilities, which encompass protein cloning, expression, purification, and structural determination. SARomics specializes in kinase structures and fragment-based drug discovery, providing pre-made kinase-ligand complexes to assist in drug discovery projects. Additionally, the company delivers structure-based drug discovery services such as hit identification, optimization, and lead generation, along with computational chemistry and protein optimization services. By facilitating insights into how drug substances and target molecules interact, SARomics supports the efficient development of new pharmaceuticals.